Disease, Disability, and Injury Prevention and Control Special Emphasis Panel “Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 8),” Request for Application Number (RFA) DP07-002

---
identifier: "/us/fr/E7-7245"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel “Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 8),” Request for Application Number (RFA) DP07-002"
title_number: 0
title_name: "Federal Register"
section_number: "E7-7245"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel “Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 8),” Request for Application Number (RFA) DP07-002"
positive_law: false
currency: "2007-04-17"
last_updated: "2007-04-17"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E7-7245"
document_type: "notice"
publication_date: "2007-04-17"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "72 FR 19207"
fr_volume: 72
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel “Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 8),” Request for Application Number (RFA) DP07-002

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel.

*Time and Date:* 12 p.m.-4 p.m., June 12, 2007 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of research grant applications in response to RFA DP07-002, “Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panel 8).”

**FOR FURTHER INFORMATION CONTACT:**

Maurine Goodman, M.A., M.P.H., Scientific Review Administrator, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS D72, Atlanta, GA 30333, telephone 404-639-4737.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: April 10, 2007.

Elaine L. Baker,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.